NCT03025360 Expanded Access to Provide Larotrectinib for the Treatment of Cancers With a NTRK Gene Fusion Status APPROVED_FOR_MARKETING Phase N/A
NCT03023722 Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT03012347 Evaluation of a Gel Sunscreen in Controlled Use Conditions (208/2016) Status COMPLETED Phase NA
NCT03010722 Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy Status COMPLETED Phase N/A
NCT03004534 A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide Status COMPLETED Phase EARLY_PHASE1
NCT03003442 Effects of Supradyn® Energy 3RDA on Fatigue/Stress, Substrate Metabolism During Exercise and Demanding Cognitive Tasks Status COMPLETED Phase NA
NCT03002922 Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating (821/2016) Status COMPLETED Phase NA
NCT03002220 Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status Status COMPLETED Phase PHASE2
NCT02992288 A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction Status COMPLETED Phase PHASE2
NCT02991131 Sivextro in Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global Observational Study Status TERMINATED Phase N/A